201
Views
3
CrossRef citations to date
0
Altmetric
Original Article: Research

Ceramide participates in lysosome-mediated cell death induced by type II anti-CD20 monoclonal antibodies

, &
Pages 1863-1868 | Received 01 Jul 2014, Accepted 19 Oct 2014, Published online: 14 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fan Zhang, Junlan Yang, Huafei Li, Moyan Liu, Jie Zhang, Lichao Zhao, Lingxiong Wang, RuiXia LingHu, Fan Feng, Xudong Gao, Biqin Dong, Xiaohan Liu, Jian Zi, Weijing Zhang, Yi Hu, Jingkun Pan, Lei Tian, Yazuo Hu, Zhitao Han, Honghong Zhang, Xiaoning Wang & Lei Zhao. (2016) Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localization. OncoImmunology 5:5.
Read now

Articles from other publishers (2)

Alfredo Pherez-Farah, Rosa del Carmen López-Sánchez, Luis Mario Villela-Martínez, Rocío Ortiz-López, Brady E. Beltrán & José Ascención Hernández-Hernández. (2022) Sphingolipids and Lymphomas: A Double-Edged Sword. Cancers 14:9, pages 2051.
Crossref
Simon Latour, Marion Zanese, Valérie Le Morvan, Anne-Marie Vacher, Nelly Menard, Fontanet Bijou, Francoise Durrieu, Pierre Soubeyran, Ariel Savina, Pierre Vacher & Laurence Bresson-Bepoldin. (2019) Role of Calcium Signaling in GA101-Induced Cell Death in Malignant Human B Cells. Cancers 11:3, pages 291.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.